Bioanalysis

Papers
(The median citation count of Bioanalysis is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-01-01 to 2025-01-01.)
ArticleCitations
Development and validation of an ELISA method for quantification of the anti-HER3 antibody HMBD-001 in human serum65
Evaluation of hemaPEN ® sampling device for measurement of cocaine and metabolites in capillary blood by LC-MS/MS37
Quantitation of Ivosidenib in Human Plasma Via LC–MS/MS and its Application in Clinical Trials27
Assay pH and Critical Reagent Optimization in Measuring Concentrations of a Monoclonal Antibody and its Target26
Volumetric Absorptive Microsampling as An Effective Microsampling Technique for LC–MS/MS Bioanalysis of Biomarkers in Drug Discovery26
Development, validation and application of a liquid chromatography–tandem mass spectrometry method for quantifying lurasidone in dried blood spot samples25
Covalent organic frameworks: spotlight on applications in the pharmaceutical arena24
Greenness assessment of microextraction techniques in therapeutic drug monitoring24
Sample Preparation in Capillary Electrophoresis for the Determination of Small Molecule Drugs and Metabolites in Urine22
Two decades of immunocapture liquid chromatography tandem mass spectrometry for pharmaceutical discovery and development: reflections and recommendations for optimal deployment21
Critical reagent considerations for immunogenicity assay development for bispecific biotherapeutic candidates21
Good Clinical Practices in the Bioanalytical Laboratory20
Comparative pharmacokinetic study of Anisodamine Hydrobromide tablets and injection in septic acute lung injury rats18
Rapid Development of Analytical Methods for Evaluating Pandemic Vaccines: A Covid-19 Perspective17
Single-Analyte Biomarker Assays for Pharmacodynamic or Safety Assessment During Biotherapeutic Development17
Biomonitoring of Arsenic, Lead, Manganese and Mercury in Hair from a Presumably Exposed Uruguayan Child Population15
A Blood-Based, Metabolite and Demographic Characteristic Markers Panel For The Diagnosis of Alzheimer's Disease15
LC–MS/MS Methods for Direct Measurement of Sepiapterin and Tetrahydrobiopterin in Human Plasma and Clinical Applications15
Achieving Routine Application of Dried Blood Spots for Erythropoietin Receptor Agonist Analysis in Doping Control: Low-Volume Single-Spot Detection at Minimum Required Performance Level14
Decentralized Clinical Trial Design Using Blood Microsampling Technology for Serum Bioanalysis14
Calprotectin as a Biomarker in Rheumatoid Arthritis: The Potential Predictive Value of Response to Treatment14
In Vitro Immunogenicity Prediction: Bridging between Innate and Adaptive Immunity14
Challenges of Implementing Ultrahigh-Throughput Mass Spectrometry in Absorption, Distribution, Metabolism and Excretion Bioanalysis14
Immunocapture LC–MS(/MS) Assays for Biotherapeutic and Biomarker Proteins: The European Bioanalysis Forum Continuing Discussions on Scientific and Regulatory Challenges13
Digital Image Colorimetry for Determination of Ethanol in Exhaled Breath Condensate13
LC–MS Bioanalysis of Protein Biomarkers and Protein Therapeutics in Formalin-Fixed Paraffin-Embedded Tissue Specimens13
Empowering Peptidomics: Utilizing Computational Tools and Approaches13
In Vitro Study and Pharmacokinetic Evaluation of Sitagliptin Phosphate Enantiomers in Rat Plasma13
Meet the Editorial Board – An Interview with Min Meng and Transitions from Small Regional Labs to Global CRO11
Application of Novel Plasma Separation Filter Cards for Quantification of Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Di/Triphosphates in Dried Blood Spots Using Lc–Ms11
Free Hemoglobin Determination at Patients’ Bedside to Evaluate Hemolysis11
Application of a new volumetric microsampling device for quantitative bioanalysis of immunosuppression11
Bioanalysis of INCB000928 in hemodialysate: prevention of nonspecific binding and validation of surrogate matrices10
Prediction of frozen virus stability based on degradation mechanisms, real-time data and modeling10
Novel Techniques and the New Age of Biomarkers: Panel Discussion Report9
Feedback from the Sixth European Bioanalysis Forum Young Scientist Symposium9
Innovation in Bioanalytical Strategies and in vitro Drug–drug Interaction Study Approaches in Drug Discovery9
Multidimensional Chromatography Platforms: Status and Prospects9
An Ultrasensitive LC–MS/MS Method and Application to Clinical Dose-Range Finding for Glycopyrrolate via an e-Nebulizer9
Criteria of Slope and Endogenous Level for Selection of Matrix in the Quantitation of Endogenous Compounds by LC-MS/MS8
Recommendations for the Content and Management of Certificates of Analysis for Reference Standards from the GCC for Bioanalysis8
Dried Matrix Spots in Forensic Toxicology8
Stability of Nafamostat in Intravenous Infusion Solutions, Human Whole Blood and Extracted Plasma: Implications for Clinical Effectiveness Studies8
Label-Free Immunosensing of Telomerase Using Bio-Conjugation of Biotinylated Antibody to Poly(Chitosan) Gold Nanoparticles8
Validation of High-Throughput, Semiquantitative Solid-Phase Sarscoronavirus-2 Serology Assays in Serum and Dried Blood Spot Matrices8
Approaches to Overcome the Challenge of Sample Stability for Flow Cytometry Analysis in Clinical Trials8
Solutions for Hematocrit Bias in Dried Blood Spot Hormone Analysis7
The importance of Quality Critical Reagents for the Entire Developmental Lifecycle of a Biopharmaceutical: A Pharmacokinetic Case Study7
A Brave New World?7
Advancements in Practical and Scientific Bioanalytical Approaches to Metabolism Studies in Drug Development7
A Biomarker Assay Validation Approach Tailored to The Context of Use and Bioanalytical Platform7
Bioanalytical Challenges and Strategies of Crispr Genome Editors7
LC–MS/MS Assay of Fluoropezil and Its Two Major Metabolites in Human Plasma: An Application to Pharmacokinetic Studies7
Critical Reagents: Evolution of WRIB Recommendations on Critical Reagents7
Development of a selective, sensitive and robust oxyntomodulin dual monoclonal antibody immunoassay7
A Bridging Immunogenicity Assay for Anti-Cabiralizumab Antibodies: Overcoming the Low Assay Cut Point and Drug Tolerance Challenges7
Towards a More Patient-Centric Assessment of Immunogenicity for Low-Risk Biologics in Immuno-Oncology Clinical Trials7
A Simple Isotope-Labeled UHPLC–MS/MS Assay for Simultaneous Quantification of Methotrexate, Imatinib and Dasatinib6
Chromatographic analysis of ciprofloxacin and metronidazole in real human plasma: green analytical chemistry perspective6
Solid-Phase Microextraction for Assessment of Plasma Protein Binding, a Complement to Rapid Equilibrium Dialysis6
Analytical Techniques for Monitoring of Toluene and Xylene Exposure Biomarkers Hippuric Acid and Methylhippuric Acid in Human Urine Samples6
Green Bioanalysis: An Innovative and Eco-Friendly Approach for Analyzing Drugs in Biological Matrices6
Analysis of Tigecycline in the Cerebrospinal Fluid and Serum of Patients with Acinetobacter Baumannii Central Nervous System Infection6
Degradation of Vancomycin in External Quality Assessment Samples is a Factor to Underestimate Its Concentration6
Bioanalysis by LC-MS/MS and Preclinical Pharmacokinetic Interaction Study of Ribociclib and Oleanolic Acid6
Validation of an HPLC Method for Estimation of Cefotaxime from Dried Blood Spot: Alternative to Plasma-Based PK Evaluation in Neonates6
Fabry Disease Biomarkers in Patients Switched From Enzyme-Replacement Therapy to Migalastat Oral Chaperone Therapy6
Technique Development of High-Throughput and High-Sensitivity Sample Preparation and Separation for Proteomics6
Comparing Singlet and Duplicate Immunogenicity Assay in Human Plasma for Pembrolizumab Using Gyrolab®6
Biomarker Context-Of-Use: How Organizational Design Can Impact the Implementation of the Appropriate Biomarker Assay Strategy6
Development of LC–MS/MS Method for Cyanoenone Triterpenoid Determination to Support CNS Tissue Distribution Study5
2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare Matrices; Regulatory Inputs ( 5
Conference Report from the European Bioanalysis Forum Workshop: toward harmonized implementation of the ICH M10 guideline5
Using Mitra Sampling to Support First-in-Human Pharmacokinetic Evaluations for PF-070590135
Unique challenges required reassessment and alterations to critical reagents to rescue a neutralizing antibody assay5
Microflow LC–MS/MS to improve sensitivity for antisense oligonucleotides bioanalysis: critical role of sample cleanness5
LC–MS/MS method for quantification of raspberry ketone in rat plasma: application to preclinical pharmacokinetic studies5
Uncovering the Green Frontier: Harnessing Deep Eutectic Solvents for Sustainable Bioanalysis5
Validation of low-volume sampling devices for pharmacokinetic analysis: technical and logistical challenges and solutions5
The case for bioanalytical analyzer5
Liquid chromatographic methods in the determination of inosine monophosphate dehydrogenase enzyme activity: a review5
2022 White Paper on Recent Issues in Bioanalysis: Fda Draft Guidance on Immunogenicity Information in Prescription Drug Labeling, Lnp & Viral Vectors Therapeutics/Vaccines Immunogenicity, Prolonga5
Quantification of a promising JNK inhibitor and nitrovasodilator IQ-1 and its major metabolite in rat plasma by LC–MS/MS5
Integrity and Efficiency: AbbVie’s Journey of Building an Integrated Nonregulated Bioanalytical Laboratory5
Pertinence of microsampling in various nonclinical and clinical studies: the ICH perspective5
Novel microchip electrophoresis–contactless conductivity method for detection and characterization of extracellular vesicles enriched for exosomes and microvesicles5
Peripheral blood mononuclear cells isolation from mouse and rabbit blood to quantify active nucleotide and define brincidofovir dose for smallpox4
Quantification of Oxalate by Novel LC–MS/MS: Assay Development, Validation and Application in Lumasiran Clinical Trials4
A Smartphone Digital Image Colorimetric Method Based on Nanoparticles for Determination of Lamotrigine4
Assessment of alteration in antiviral plasma concentration across dialysis days: computational and analytical study4
Validation and Comprehensive Analysis of Streptococcus pneumoniae IgG WHO Enzyme-Linked Immunosorbent Assay in an Indian Reference Laboratory4
Novel Hydrophilic-Phase Extraction, HILIC and High-Resolution MS Quantification of an RNA Oligonucleotide in Plasma4
Single-Day Protein LC–MS Bioanalysis: Can Next-Generation Trypsins Cut It?4
2022 White Paper on Recent Issues in Bioanalysis: Enzyme Assay Validation, BAV for Primary End Points, Vaccine Functional Assays, Cytometry in Tissue, LBA in Rare Matrices, Complex NAb Assays, Spectra4
Role of miRNA-21 in cancer and its application in electrochemical bioanalysis4
Comparison of Pharmacokinetic Study Profiles of Insulin in Rat Plasma Through Conventional Sampling and Microsampling by Micro-LC–MS/MS4
Signal-to-noise Ratio to Assess Magnitude, Kinetics and Impact on Pharmacokinetics of the Immune Response to an Adalimumab Biosimilar4
Pitfalls in bioanalytical work with a Japanese CRO or sponsor: from a project risk management perspective4
Simultaneous Determination of Four Antibiotics in Human Plasma by High-Performance LC–MS/MS: Application to Therapeutic Drug Monitoring4
ELISA array-based immunoassay for multiplex detection of osteoporosis-relevant biomarkers4
Simple Method to Determine the Concentration and Incorporation Ratio of Ruthenium-Labeled Antibodies4
Simultaneous estimation of rutin and donepezil through RP-HPLC: implication in pharmaceutical and biological samples4
Determination of Favipiravir in Human Plasma using Homogeneous Liquid–Liquid Microextraction followed by HPLC/UV4
Development and validation of an LC–MS/MS method for D- and L-2-hydroxyglutaric acid measurement in cerebrospinal fluid, urine and plasma: application to glioma4
The advantages of working with a central laboratory for conducting clinical trials4
A Survey of Pharmacokinetic Bioanalytical Methods in Biosimilar Biological License Applications for the Assessment of Target and Antidrug Antibody Effects4
Novel Sorptive Microextraction Approaches in Bioanalysis: The Paradigm of Endocrine Disruptors4
Feedback from the 8th European Bioanalysis Forum Young Scientist Symposium4
Challenges and Current Advances in the Methodology of Thyroglobulin Measurements4
A Low-Voltage Electro-Membrane Extraction for Quantification of Imatinib and Sunitinib in Biological Fluids4
An LC-MS/MS method for the determination of Lifitegrast in human plasma and tear and its application in the pharmacokinetic study4
LC-MS/MS-based bioanalysis of branched-chain and aromatic amino acids in human serum4
A platform immunoassay for the quantification of biotherapeutics with glycine-serine linkers4
Advancing the Use of Molecularly Imprinted Polymers in Bioanalysis: The Selective Extraction of Cotinine in Human Urine3
Development and application of a multi-sugar assay to assess intestinal permeability3
A Singlicate Immunogenicity Method to Detect Anti-Polyethylene Glycol Antibodies: Pre- and Post-Dose of PEGylated Therapies3
Quantitative Chromatographic Method Development for Residual Lidocaine in Topical Systems and Biological Samples3
Critical Reagents in Flow Cytometry, Instrumentation and Application in Drug Discovery Development3
Solid-Phase Extraction of Gallic Acid and Ascorbic Acid in Fruits Using Polymerized Deep Eutectic Solvent-Modified Substrate3
Less is More: An Ecological and Economic Point of View on Appropriate Use of Lab Testing for Covid-19 Patients3
Expanding Assay Range to Accommodate a Monoclonal Antibody Therapeutic Quantification in Blood and Cerebrospinal Fluid3
A New Approach with Dried Plasma Spots: A Rapid Determination of Antidepressants and Antipsychotics by Fast GC–MS3
A Cell-Based FcRn-dependent Recycling assay for Predictive Pharmacokinetic assessment of Therapeutic Antibodies3
Application of Middle-Down Approach in Quantitation and Catabolite Identification of Protein by LC–high-Resolution Mass Spectrometry3
Iron oxide nanozymes as versatile analytical tools: an overview of their application as detection technique3
A Robust Enzyme-Linked Immunosorbent Assay to Measure Serum Ramucirumab Concentrations3
A comprehensive LC–MS based study of factors influencing biotinylation of critical reagents3
Green Sample Preparation in Bioanalysis: Where Are We Now?3
Development and Validation of LC–MS/MS Method for Quantitation of Sodium Oligomannate in Human Plasma, Urine and Feces3
Progress Towards Global Standardization for Quantitative Flow Cytometry3
Flow cytometry vs conventional methods for the evaluation of anti-PF4/heparin antibodies: a single center study3
Recent advances in gold nanoparticle-based colorimetric aptasensors for chemical and biological analyses3
Development of a Novel Elisa to Detect Total Factor D in the Presence of High Levels of Pegylated Anti-Factor D Fab3
Bioanalysis of tucatinib and metabolite, and a five-way cross-validation to support clinical pharmacokinetic analysis3
Lacidipine: Review of Analytical Methods Developed for Pharmaceutical Dosage forms and Biological Fluids3
Deploying a Rapid Point-Of-Care Polymerase Chain Reaction Test for Sars-Cov-2 in a Clinical Research Unit to Ensure Healthy Volunteer Safety3
The European Bioanalysis Forum recommendation on establishing appropriate drug tolerance levels in antidrug antibody assays3
Determination and Validation of Aprepitant in Rat Plasma using LC−MS/MS3
Hollow Fiber-in-Syringe Equilibrium Sampling Through Supported-Liquid Membrane for Evaluation of Drug-Plasma Binding3
Stability of Nonsteroidal Anti-Inflammatory Drugs in Urine and Solution: Effects of Degradation on Analytical Assessment3
Quantitation of Vistusertib by UHPLC-MS/MS in Rat Plasma and its Application to a Pharmacokinetic Study3
Measurement of Free Fraction, Total Concentration and Protein Binding for Testosterone, Triiodothyronine and Thyroxine3
Sensitive LC-MS/MS Quantification of Unconjugated Maytansinoid DM4 and its Metabolite S-methyl-DM4 in Human Plasma3
A New Method for the Therapeutic Drug Monitoring of Chlorpromazine in Plasma by Gas Chromatography–Mass Spectrometry Using Dispersive Liquid–Liquid Microextraction3
Development of an Immunoassay for Aglycosylated Murine IgG1 in Mouse Serum via Generation of a Specific Tool Antibody3
Inclusion of dilution quality control samples in quantitative LC-MS bioanalysis3
Conduct of Remote Inspections: Challenges and Progress3
Highlights From the 25th International Reid Bioanalytical Forum2
A High-Speed Microscopy System Based on Deep Learning to Detect Yeast-Like Fungi Cells in Blood2
Determination of IQZ23 in Rat Plasma using LC-MS/MS: Consideration for Matrix Effect and Internal Standard Interference2
A Novel Hydrophilic Interaction Chromatography Assay Characterization of 4-Pyridoxic Acid, an Emergent Renal Organic Anion Transporter 1/3 Transporter Biomarker2
Effective Biomarker Measurement is Key for Biotherapeutic Development2
Determination of carbamazepine in fingerprints: a feasibility study to evaluate adherence in epilepsy patients2
Novel assay format for total anti-adeno-associated virus antibody detection with low capsid consumption and built-in specificity control2
Comparison of Pharmacokinetic Profiles in Hypoalbuminemia and Healthy Rats After Parecoxib Sodium Injection by LC–MS/MS2
16 th GCC Closed Forum: ICH M10 implementation; NGS, qPCR/dPCR, flow cytometry validation; tissue biomarkers; IS response; immunogenicity harmonization; bioanalytica2
WRIB Poster Awards Winners 20232
LC–MS/MS Analysis and Pharmacokinetics of Daidzein and its 7-O-Glucuronide in Rats After Oral Administration of 7-O-L-Valyl Carbamate Prodrug2
Development of a Meso Scale Discovery Ligand-Binding Assay for Measurement of Free (Drug-Unbound) Target in Nonhuman Primate Serum2
Evaluating the Use of Locked Nucleic Acid Capture Probes in Hybrid LC–MS/MS Analysis of siRNA Analytes2
Introducing the 2023 Bioanalysis Special-Themed Issue on Laboratory Structure and Management for Nonregulated Bioanalysis2
Meet the Editorial Board: An Introduction to and Insights from Fumin Li2
Preclinical Pharmacokinetics of 4-Hydroxy Isoleucine Using Lc–Ms/Ms: A Potential Polycystic Ovary Syndrome Phytopharmaceutical Therapeutics2
Validation of Enantioseparation and Quantitation of an Active Metabolite of Abrocitinib in Human Plasma2
Lot-to-lot Reproducibility, Stability and Life Cycle Management of Antibody Reagents for Flow Cytometry2
Assessing prognosis by quantifying FcγRIIa on fixed platelets2
Development of a Sensitive HPLC Method with Fluorescence Detection for the Determination of Motilin in Human Plasma2
Bioanalysis of the Bicycle®Toxin Conjugate BT5528 and Released Monomethyl Auristatin E via Liquid Chromatography–Tandem Mass Spectrometry2
Determination of Cortisol in Hair Using Uhplc–Ms/Ms: Application to Patients Admitted for Ethanol Dependence Treatment2
UHPLC-MS/MS for Plasma Lamotrigine Analysis and Comparison with a Homogenous Enzyme Immunoassay2
2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability &2
Determination of Levetiracetam by GC-MS and Effects of Storage Conditions and Gastric Digestive Systems on Drug Samples2
Validation and Application of Hybridization Liquid Chromatography-Tandem Mass Spectrometry Methods for Quantitative Bioanalysis of Antisense Oligonucleotides2
How the Covid-19 Pandemic is Changing Clinical Trial Conduct and Driving Innovation in Bioanalysis2
Simultaneous Determination of Duloxetine and 4-Hydroxy Duloxetine Glucuronide in Human Plasma and Back-Conversion Study2
Pharmacokinetics and apparent Michaelis constant for metabolite conversion of sorafenib in healthy and hepatocellular carcinoma-bearing rats2
Development of a UPLC–MS/MS Method for Determination of a Dual EZH1/2 Inhibitor UNC1999 in Rat Plasma2
Understanding Drug–Protein Binding and ADME Studies for DMPK2
Critical Reagent Characterization and Re-Evaluation to Ensure Long-Term Stability: Two Case Studies2
Handling Unstable Analytes: Literature Review and Expert Panel Survey by the Japan Bioanalysis Forum Discussion Group2
High-resolution mass spectrometry for glycoproteomics2
Key Points of Technical Review for the Registration of Sars-Cov-2 Antigen/Antibody Tests2
High-Sensitivity Workflow for LC–MS-Based Analysis of GALNAC-Conjugated Oligonucleotides: A Case Study2
Development and multicenter validation of an LC–MS-based bioanalytical method for antisense therapeutics2
Conference report for the 10th China Bioanalysis Forum annual meeting2
COVID-19: Bioanalytical Considerations, Contributions and Lessons–Part 12
The Potential of Oral Fluid in 1Drug Monitoring: An Update2
Quantification of levetiracetam in plasma and urine and its application to a pharmacokinetic study of traumatic brain injury patients2
Development of pseudotyped VSV-SARS-CoV-2 spike variants for the assessment of neutralizing antibodies2
Quantitative Determination of Cpd118, A Novel FBPase Inhibitor, in Dog Plasma by HPLC–MS/MS2
Comprehensive Performance Evaluation of Ligand-Binding Assay–LC–MS/MS Method for Co-Dosed Monoclonal Anti-SARS-CoV-2 Antibodies (AZD7442)2
Strategy and Validation of a Nonclinical Generic Plug-and-Play Antidrug Antibody Method for Human Monoclonal Antibody Biotherapeutics2
Risk-Based Approach of Bioanalytical Methods for Clinical Immunogenicity Assessment of Multidomain Biotherapeutics2
Method Development Workflow for Quantifying Protein Biomarkers by Hybrid LC–MS/MS2
Volumetric Absorptive Microsampling Coupled with Hybridization LC–MS/MS for Quantitation of Antisense Oligonucleotides2
2023 White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vacc2
Monitoring of Hemoglobin and Erythropoiesis-Related mRNA with Dried Blood Spots in Athletes and Patients2
Challenges with Development of a Pharmacokinetics Assay to Measure a Variably Glycosylated Fusion Protein2
Development of a sensitive LC-MS/MS assay to support human microdose study for an oral agonist of the GLP-1 receptor2
Thyroxine Biosensors: A Review on Progress and Challenges2
Development, Validation and Application of an Ion-Pair Reversed-Phase Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Nusinersen2
The synergy of nucleic acid amplification and miniaturized systems in enhancing liquid biopsy applications2
A Validated Method for the Determination of Hematocrit in Dried Blood Spots Using Image Analysis2
Multi-Laboratory Evaluation of Immunoaffinity LC–MS-Based Glucagon-Like Peptide-1 Assay2
New Development and Update on China Bioanalysis Forum2
Ultrasensitive Digital Immunoassays for SOD1 Conformation in Amyotrophic Lateral Sclerosis2
Small Extracellular Vesicle Biomarkers in Breast Cancer: A Real-Time Snapshot for Early Diagnosis and Prognosis?2
Corrigendum2
Cloud Solutions for GxP Laboratories: Considerations for Data Storage2
Perspective on LC-MS(/MS) for biotherapeutic and biomarker proteins in research and regulated Bioanalysis: a consolidation of more than a decade of experience across the European Bioanalysis Forum com2
Diversity and Inclusion in the Bioanalytical Industry: An Interview with Nigel Phillip Danielson-Ewing2
Harmonization of Vaccine Ligand Binding Assays Validation2
Efficiency of Pooled Surveillance Testing in Academic Labs to Detect and Inhibit Covid-19 Outbreaks2
CRISPR-Cas13a-Based Diagnostic Method for Chlamydia Trachomatis from Nongonococcal Urethritis1
An immunoassay for the quantification of phosphorylated α-synuclein at serine 129 in human cerebrospinal fluid1
Immunoassay Automation is Driving Advancements in Cell and Gene Therapies1
UPLC–MS/MS method for fluconazole determination in plasma and its application in Mexican patients with candidaemia1
Virus Reduction Neutralization Test and LI-COR Microneutralization Assay Bridging and WHO International Standard Calibration Studies for Respiratory Syncytial Virus1
Capillary Electrophoresis Mass Spectrometry for Metabolomics: Reflecting on the Next Steps1
Phage-Derived Anti-Idiotype and Anti-YTE Antibodies in Development of MK-1654 Pharmacokinetic and Immune Response Assays1
Validated HPLC Method for Ceftriaxone from Dried Blood Spots for Pharmacokinetic Studies and Therapeutic Drug Monitoring in Neonatal Population1
Bioanalysis of free antisense oligonucleotide payload from antibody–oligonucleotide conjugate by hybridization LC-MS/MS1
Validation of an LC–MS/MS method for the determination of sotorasib, a KRAS G12C inhibitor, in human plasma1
Interference from anti-drug antibodies on the quantification of insulin: a comparison of an LC-MS/MS assay and immunoassays1
Development and validation of methods that enable high-quality droplet digital PCR and hematological profiling data from microvolume blood samples1
A comparison of branched DNA and reverse transcriptase quantitative polymerase chain reaction methodologies for quantitation of lipid nanoparticle encapsulated mRNA1
Quantitation of a Plasma Biomarker Profile for the Early Detection of Gaucher Disease type 1 Patients1
Whole Blood Stability Evaluation of Monoclonal Antibody Therapeutics Using Volumetric Absorptive Microsampling1
Diversity and Inclusion in the Bioanalytical Industry: An Interview with Shefali R Patel1
The GSK Bioanalytical Hub Model in Bioanalysis: Maximizing the Synergies of Co-Locating Various Platforms in Support of Regulated and Nonregulated Study end Points1
Critical Reagent Generation, Characterization, Handling and Storage Workflows: Impact on Ligand Binding Assays1
Back to nature: immunocapture and related methods for the selective analysis of pharmaceutical and biomedical samples1
Bioanalysis Rising Star Award 2024: interviews with the finalists1
Bioanalysis of INCB000928 in Human Saliva: Nonspecific Binding and Inhomogeneous Concentration1
Development of a Lc–Ms/Ms Method for the Quantification of Toxic Payload Dm1 Cleaved from Bt1718 in a Phase I Study1
Detection of Sars-Cov-2At the Point of Care1
BiSim Tool: a binding simulation tool to aid and simplify ligand-binding assay design and development1
Quantitation of Reduced Il-33 Levels in Human Serum: Mitigating Interference From Endogenous Binding Partners1
Development of Fe 3 O 4 /Reduced Graphene Oxide Nanocomposite-Based Dispersive Solid-Phase Extraction for the Quantification of Fi1
Development and Validation of a High Performance Liquid Chromatography–MS/MS Method for Determination of SOMCL-15-290 in a First-in-Human Study1
An LC–MS/MS method for determination of the bromodomain inhibitor ZEN-3694 and its metabolite ZEN-3791 in human plasma1
Bioanalytical LC–MS/MS method for simultaneous estimation of atorvastatin, its major active metabolites and ezetimibe1
WRIB Poster Awards Winners 20221
A European Bioanalysis Forum recommendation for requiring a context-of-use statement for successful development and validation of biomarker assays1
Simultaneous isotyping and semi-quantitation of anti-drug antibodies to an IgG1 biotherapeutic using hybrid LBA-LC-MS/MS1
A Sensitive LC–MS/MS Assay to Quantitate Free Payload Aur0101 from ADC PYX-201 in Rat and Monkey Plasma1
A Competitive Ligand-Binding Assay to Detect Neutralizing Antibodies to a Bispecific Drug Using a Multiplex Meso Scale Discovery Platform1
The investigation of connection between anticoagulant therapy and vitamin K homologues in human determined by LC–MS/MS1
Use of RNA biomarkers in the antidoping field1
Cross-validation of pharmacokinetic assays post-ICH M10 is not a pass/fail criterion1
0.293869972229